Repeat prostate biopsy in the Prostate, Lung, Colorectal and Ovarian cancer screening trial

BJU International

Volumn 99, Issue 4, 2007, Pages 775-779

  Pinsky, Paul F ^a,f   Crawford, E David ^b   Kramer, Barnett S ^a   Andriole, Gerald L ^c   Gelmann, Edward P ^d   Grubb, Robert ^c   Greenlee, Robert ^e   Gohagan, John K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e MARSHFIELD CLINIC   (United States)

^f EPN 3064 ^*  (United States)

Author keywords

Digital rectal examination; Prostate cancer; Prostate specific antigen; Repeat prostate biopsy; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DISEASE MARKER; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REPEAT PROCEDURE; RISK FACTOR;

AGED; BIOPSY, NEEDLE; COHORT STUDIES; DIGITAL RECTAL EXAMINATION; FALSE NEGATIVE REACTIONS; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 33947321465     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06708.x     Document Type: Article

References (13)

1. Fink KG, Hutarew G, Lumper W, Jungwirth A, Dietze O, Schmeller NT. Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsies. Urology 2001; 58: 735-39
2. Djavan B, Ravery V, Zlotta A et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 2001; 166: 1679-83
3. Lopez-Corona E, Ohori M, Wheeler TM et al. Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate. J Urol 2006; 175: 923-8
4. Steiner H, Moser P, Hager M et al. Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening population. Prostate 2004; 58: 277-82
5. Prorok P, Andriole GL, Bresalier RS et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21 (Suppl.): 273S-309S
6. Pinsky PF, Andriole GL, Kramer BS et al. Prostate biopsy following a positive screen in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Urol 2005; 173: 746-51
7. Andriole GL, Levin DL, Crawford ED et al. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 2005; 97: 433-8
8. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons, Inc, 1980
9. Eggener SE, Roehl KA, Catalona WJ. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6-4.0 ng/ml and an initially negative biopsy. J Urol 2005; 174: 500-4
10. Garzotto M, Park Y, Mongoue-Tchokote S et al. Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies. Cancer 2005; 104: 1911-7
11. Borboroglu PG, Sur RL, Roberts JL, Amling CL. Repeat biopsy strategy in patients with atypical proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol 2001; 166: 866-70
12. Nam RK, Toi A, Trachtenberg J et al. Variation in patterns of practice in diagnosing screen-detected prostate cancer. BJU Int 2004; 94: 1239-44
13. Naya Y, Ayala AG, Tamboli P, Babaian RJ. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? Urology 2004; 63: 503-8